Literature DB >> 10639205

Pulmonary manifestations of neuromuscular disease with special reference to Duchenne muscular dystrophy and spinal muscular atrophy.

D Gozal1.   

Abstract

Deterioration of respiratory function in patients with neuromuscular disorders is primarily responsible for the high mortality associated with these diseases. A review of Duchenne muscular dystrophy and spinal muscular atrophy, the leading neuromuscular disorders affecting children, will be followed by a critical analysis of the various pathophysiological mechanisms underlying respiratory manifestations in these patients. Among such mechanisms, the role of muscular weakness in preservation of lung function, mucociliary clearance, gas exchange at rest and during exercise, and respiratory control during wakefulness and sleep will be examined in detail. In addition, the potential benefits of respiratory muscle training and of early diagnosis and clinical intervention will be delineated. This review underscores the importance of periodic assessment of pulmonary function during wakefulness and sleep in children affected by neuromuscular diseases as an essential component of multidisciplinary care aimed at improving long-term morbidity, survival, and quality of life. Copyright 2000 Wiley-Liss, Inc.

Entities:  

Mesh:

Year:  2000        PMID: 10639205     DOI: 10.1002/(sici)1099-0496(200002)29:2<141::aid-ppul9>3.0.co;2-y

Source DB:  PubMed          Journal:  Pediatr Pulmonol        ISSN: 1099-0496


  41 in total

1.  Outcome of children with neuromuscular disease admitted to paediatric intensive care.

Authors:  K Yates; M Festa; J Gillis; K Waters; K North
Journal:  Arch Dis Child       Date:  2004-02       Impact factor: 3.791

Review 2.  Respiratory muscle fibres: specialisation and plasticity.

Authors:  B Polla; G D'Antona; R Bottinelli; C Reggiani
Journal:  Thorax       Date:  2004-09       Impact factor: 9.139

3.  Sleep, sleep disordered breathing, and nocturnal hypoventilation in children with neuromuscular diseases.

Authors:  Raanan Arens; Hiren Muzumdar
Journal:  Paediatr Respir Rev       Date:  2010-03       Impact factor: 2.726

4.  Cephalometric findings in facioscapulohumeral muscular dystrophy patients with obstructive sleep apneas.

Authors:  Giacomo Della Marca; Francesca Pantanali; Roberto Frusciante; Emanuele Scarano; Alessandro Cianfoni; Lea Calò; Serena Dittoni; Catello Vollono; Anna Losurdo; Elisa Testani; Salvatore Colicchio; Valentina Gnoni; Elisabetta Iannaccone; Benedetto Farina; Tommaso Pirronti; Pietro A Tonali; Enzo Ricci
Journal:  Sleep Breath       Date:  2010-02-20       Impact factor: 2.816

5.  rAAV6-microdystrophin preserves muscle function and extends lifespan in severely dystrophic mice.

Authors:  Paul Gregorevic; James M Allen; Elina Minami; Michael J Blankinship; Miki Haraguchi; Leonard Meuse; Eric Finn; Marvin E Adams; Stanley C Froehner; Charles E Murry; Jeffrey S Chamberlain
Journal:  Nat Med       Date:  2006-07-02       Impact factor: 53.440

6.  Diaphragm remodeling and compensatory respiratory mechanics in a canine model of Duchenne muscular dystrophy.

Authors:  A F Mead; M Petrov; A S Malik; M A Mitchell; M K Childers; J R Bogan; G Seidner; J N Kornegay; H H Stedman
Journal:  J Appl Physiol (1985)       Date:  2014-01-09

Review 7.  Sleep-disordered breathing in patients with neuromuscular disease.

Authors:  Mohamad Ammar Albdewi; Giuseppe Liistro; Riëm El Tahry
Journal:  Sleep Breath       Date:  2017-07-12       Impact factor: 2.816

8.  The effect of scoliosis surgery on pulmonary function in spinal muscular atrophy type II patients.

Authors:  Shih-Hsiang Chou; Gau-Tyan Lin; Po-Chih Shen; Yi-Jing Lue; Cheng-Chang Lu; Yin-Chun Tien; Yen-Mou Lu
Journal:  Eur Spine J       Date:  2016-11-02       Impact factor: 3.134

Review 9.  Neuromuscular disorders and sleep.

Authors:  Ibrahim Oztura; Christian Guilleminault
Journal:  Curr Neurol Neurosci Rep       Date:  2005-03       Impact factor: 5.081

10.  Respiratory dysfunction in unsedated dogs with golden retriever muscular dystrophy.

Authors:  Justin C DeVanna; Joe N Kornegay; Daniel J Bogan; Janet R Bogan; Jennifer L Dow; Eleanor C Hawkins
Journal:  Neuromuscul Disord       Date:  2013-10-24       Impact factor: 4.296

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.